FDA Investigator Logan T Williams

Logan T Williams has inspections in 2 countries as of 28 Sep 2023. Logan T Williams has collaborated with a combinined 3249 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
31
Last Inspection Date:
28 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada
Co-Investigator(s):
Abby E Pelletier, Alanna Lmussawwir Bias, Andrew J Barrowcliff, Anna M Brannen, Anthony J Ladner, Audrey N Vigil, Ava M Bowman, Azza Talaat, Bailey A Uetrecht, Bei Y He, Bethany L Subel, Brenda C Hamilton, Brenda S Zimmer, PhD, Brett R Havranek, Brigitte K Hofmann, Burnell M Henry, Byeongtaek Oh, Carl A Huffman, III, Carla A Norris, Chiaochun J Wang, Christina Capacci Daniel, PhD, Christine E Kelley, Christopher T Middendorf, Claire M Minden, Concepcion Cruz, Jr, Constantin Y Philopoulos, Cristina Ausin Moreno, PhD, Cristina Ausin Moreoo, PhD, Cynthia M Goudeau, Cynthia T Cain, Daniel J Gorski, Daniel J Roberts, David A Oluwo, David A Paterson, David J Eide, David P Moorhead, Dell S Moller, Derrionna M Epps, Diane L Raccasi, Doan T Nguyen, PharmD, Dustin K Hampton, Eboni S Funderburk, Edwin Jao, Elisa A Nickum, Elizabeth Ll Edwards, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Enrico Joset Mangahis, Eric C Nielsen, Eric M Padgett, Erika V Butler, Esther C Broner, PhD, Frederick M Lochner, Gam S Zamil, Gloria J Champagne, Hans T Meyers, Helen B Ricalde, Hugh M Mcclure, II, Hyung Yul Lee, Ifueko Osemwota, Isabel Y Espinosa, Jacob G Lutz, James A Lane, James G Marsh, James I Giefer, James L Finn, Jamie L Dion, Javonica F Penn, Jeffrey A Sommers, Jeffrey D Meng, Jennifer L Gustavus, Jennifer L Jager, Jerry J Corwin, Jill J Tillman, Jon P Antoniou, Joshua P Wireman, Joshua S Hunt, Joshua Wireman, Joslyn K Brunelle, PhD, Joy Rkozlowski Klena, Karen C Daugherty, Karen M Montgomery (KMM), Kathleen D Culver, Kathleen Dant Ceckner, Kenneth E Felkley, Kenneth H Williams, Larry K Austin, Lauren N Howard, Lauren N Smith, Lauren R Collins, LCDR Sean Byrd, Linda F Murphy, Lindsey M Schwierjobann, Lindsey M Schwierjohann, Lisa L Flores, Lisa R Hilliar, Lynnsey A Renn, Maria Cruz Fisher, Maria I Cruz Fisher, Marianne Allen, Maribeth G Grattan, Maribeth G Niesen, Mark E Parmon, Mark G Peterson, Matt D Suedkamp, Matthew M Schuckmann, Matthew Schuckman, Meisha R Sampson, Meisha Waters, Michael C Zubelewicz, Michael E Clark, Michael F Sheehan, Michael P Sheehan, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Monica E Murie, Muna Algharibeh, Muna Alghribeh, Natalie A Mickelsen, DVM, Nathan B Davis, Nicholas L Paulin, Omotunde O Osunsanmi, Paranthaman Senthamaraikannan, Patricia H Dlugosz, Patsy J Domingo, Rabia Ballica, PhD, Rafeeq A Habeeb, Raymond R Roy, PhD, Rebecca Rodriguez, Robert Barbosa, Robert J Ham, Robert M Barbosa, Roy C Stephens, Samuel A Hamblin, Sandra A Boyd, Sarah M Meng, Sarah M Napier, Sargum C Sood, Scott R Nichols, PhD, Sean R Bryd, Shannon A Gregory, Sharon K Thoma, PharmD, Sneha S Patel, Sri Ramakrishnaiah Yellela, Srinivas R Chennamaneni, PhD, State Agency, Stephanie M Mongeluzzi, Stephen D Brown, Steven P Eastham, Susan D Yuscius, Talmane J Fisher, Tamara M Kays, Tara C Alcazar, Tara L Greene, Tara L King, Tarun D Mehta, Thomas C Woods, Thomas J Arista, Timothy J Schmidt, Tracey L Harris, Vaishali J Patel, Verlinda A Narcisse, Veronica Fuentes, MS, Victoria P Quadrini, Vikas Moolchandani, Vlada Matusovsky, Wayne D Mcgrath, Wayne E Seifert, Wen Ning Chan (Sally), William A Warnick, Xiaohan Cai, PhD, Yanming An, PhD, Ying Zhang, Yiyue Zhang (nmi), PhD

Logan T Williams's Documents

Publish Date Document Type Title
August, 2021 EIR Catalent Pharma Solutions, LLC - EIR, 2021-08-02
February, 2023 FDA 483 KP Pharmaceutical Technology, Inc. - Form 483, 2023-02-03
March, 2020 FDA 483 HNC Products Inc. - Form 483, 2020-03-17
March, 2022 FDA 483 Response TMC Acquisitions LLC dba Tailor Made Compounding - Form 483R, 2022-04-04
April, 2021 FDA 483 Avantor Performance Materials, LLC - Form 483, 2021-04-14
June, 2023 FDA 483 Diversified CPC International - Form 483, 2023-06-16
June, 2021 FDA 483 Response Allergan Sales, LLC - Form 483R, 2021-07-15
September, 2022 FDA 483 Catalent Indiana, LLC - Form 483, 2022-09-01
April, 2021 FDA 483 Response Avantor Performance Materials, LLC - Form 483R, 2021-04-26
October, 2022 FDA 483 Lannett Company, Inc. - Form 483, 2022-10-21
April, 2021 EIR Avantor Performance Materials, LLC - EIR, 2021-04-14
June, 2022 FDA 483 S&B Pharma LLC DBA Alkem Laboratories - Form 483, 2022-06-17
March, 2022 FDA 483 TMC Acquisitions LLC dba Tailor Made Compounding - Form 483, 2022-03-14
June, 2021 EIR Allergan Sales, LLC - EIR, 2021-06-24
May, 2023 FDA 483 Thorn BioScience - Form 483, 2023-05-26
June, 2021 FDA 483 Allergan Sales, LLC - Form 483, 2021-06-24
September, 2022 EIR Catalent Indiana, LLC - EIR, 2022-09-01
July, 2022 FDA 483 Giles Chemical - Form 483, 2022-07-27
January, 2023 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2023-01-11
August, 2023 FDA 483 Univar Solutions USA Inc. - Form 483, 2023-08-11
May, 2023 FDA 483 RxCrossroads 3PL LLC - Form 483, 2023-05-09
June, 2023 FDA 483 Aeropres Corporation - Form 483, 2023-06-22
October, 2021 FDA 483 Whisk Products, Inc. - Form 483, 2021-10-22
January, 2023 FDA 483 Response Catalent Pharma Solutions, LLC - Form 483R, 2023-02-02
February, 2023 EIR Jubilant HollisterStier General Partnership - EIR, 2023-11-01
October, 2023 FDA 483 AGC Inc. - Form 483, 2023-10-27
December, 2023 FDA 483 Neogen Corporation - Mercer Rd. - Form 483, 2023-12-21
December, 2022 FDA 483 Nephron Pharmaceuticals - Form 483, 2022-12-02
November, 2023 FDA 483 AGC WAKASA CHEMICALS CO.,LTD. - Form 483, 2023-11-02
March, 2021 FDA 483 Neogen Corporation - Mercer Rd. - Form 483, 2021-03-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more